Variable | Odds ratio | 95% confidence interval | P value |
---|---|---|---|
First model | |||
Non-malignant hematological abnormality known on admission | 7.75 | [1.77–34.02] | 0.007 |
Indication of BMA excluding isolated TPa,b | 3.32 | [1.16–9.51] | 0.025 |
SOFA scorec | 1.19 | [1.06–1.34] | 0.003 |
Pre-BMA HScorec,d | 1.03 | [1.01–1.04] | < 0.001 |
Second model | |||
Non-malignant hematological abnormality known on admission | 6.76 | [1.51–30.38] | 0.013 |
Indication of BMA excluding isolated TPa,b | 3.82 | [1.19–12.24] | 0.024 |
SOFA—platelet-count SOFA subscorec | 1.19 | [1.04–1.35] | 0.009 |
Pre-BMA HScorec,d | 1.03 | [1.01–1.04] | < 0.001 |
Platelet count SOFA subscore 0 versus other groups | 2.14 | [0.60–7.62] | 0.239 |